Comparison of Dry Mouth in Women Treated with Extended-Release Formulations of Oxybutynin or Tolterodine for Overactive Bladder

Author： Armstrong Robert Luber Karl Peters Kenneth

Publisher： Springer Publishing Company

ISSN： 0301-1623

Source： International Urology and Nephrology, Vol.37, Iss.2, 2005-06, pp. : 247-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women

By Sand Peter Miklos John Ritter Henry Appell Rodney

International Urogynecology Journal, Vol. 15, Iss. 4, 2004-08 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

By Anderson Rodney MacDiarmid Scott Kell Sherron Barada James Serels Scott Goldberg Roger

International Urogynecology Journal, Vol. 17, Iss. 5, 2006-10 ,pp. : 502-511

Springer Publishing Company

Access to resources Recommend Favorite

By Homma Y.

World Journal of Urology, Vol. 22, Iss. 4, 2004-08 ,pp. : 251-256

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Safety, Tolerability and Efficacy of Extended-Release Tolterodine in the Treatment of Overactive Bladder

By Kreder K. Mayne C. Jonas U.

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 588-595

Elsevier

Access to resources Recommend Favorite

Once-Daily, Extended-Release Formulations of Antimuscarinic Agents in the Treatment of Overactive Bladder: A Review

By Rovner E.S. Wein A.J.

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 6-14

Elsevier

Access to resources Recommend Favorite